Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome

Ahmed Salem, Marie-Claude Asselin, Bart Reymen, Alan Jackson, Philippe Lambin, Catharine M. L. West, James P. B. O'Connor, Corinne Faivre-Finn

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)14-30
Number of pages17
JournalJournal of the National Cancer Institute
Volume110
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • POSITRON-EMISSION-TOMOGRAPHY
  • RANDOMIZED PHASE-II
  • CONTEXTUAL SYNTHETIC LETHALITY
  • FSAIIC MURINE FIBROSARCOMA
  • RADIATION ONCOLOGY GROUP
  • EPIDERMAL-GROWTH-FACTOR
  • CARBONIC-ANHYDRASE IX
  • CONTRAST-ENHANCED-MRI
  • EVERY 3 WEEKS
  • TUMOR HYPOXIA
  • NECK-CANCER
  • RADIATION-THERAPY
  • ACTIVATED PRODRUG
  • OXYGEN-ENHANCED MRI
  • PROGNOSTIC-SIGNIFICANCE

Cite this

Salem, A., Asselin, M-C., Reymen, B., Jackson, A., Lambin, P., West, C. M. L., O'Connor, J. P. B., & Faivre-Finn, C. (2018). Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome. Journal of the National Cancer Institute, 110(1), 14-30. https://doi.org/10.1093/jnci/djx160